ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
139 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 49 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 49
87% less call options, than puts
Call options by funds: $1.88M | Put options by funds: $14.6M
Holders
139
Holding in Top 10
5
Calls
$1.88M
Puts
$14.6M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$16.9M | |
| 3 | +$12.3M | |
| 4 |
LPC
Lion Point Capital
New York
|
+$9.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.76M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$11.7M | |
| 3 | -$8.5M | |
| 4 |
BlackRock
New York
|
-$7.26M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.85M |